← All Sponsors
SPONSOR

QuantumLeap Healthcare Collaborative

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Breast NeoplasmsBreast CancerBreast TumorsAngiosarcomaTNBC - Triple-Negative Breast CancerHER2-positive Breast CancerHER2-negative Breast CancerHormone Receptor Positive TumorHormone Receptor Negative TumorEarly-stage Breast Cancer
NCT01042379 Phase 2
Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Breast Neoplasms
United States View Trial →